Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Jul;65(7):2829–2836. doi: 10.1128/iai.65.7.2829-2836.1997

Macrophages and enriched populations of T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis.

B K DuChateau 1, J R Jensen 1, D M England 1, S M Callister 1, S D Lovrich 1, R F Schell 1
PMCID: PMC175398  PMID: 9199456

Abstract

Hamsters receiving both macrophages exposed to Formalin-inactivated Borrelia burgdorferi (Mphi-FBb) and enriched populations of either immune or naive T lymphocytes developed severe swelling of the hind paws when infected with B. burgdorferi. Swelling was detected 6 days after infection, peaked on day 10, and gradually decreased. Swelling was also observed in the hind paws of hamsters infused with only Mphi-FBb or only enriched populations of either immune or naive T lymphocytes after infection with B. burgdorferi. However, the swelling detected in these hamsters was less severe and of shorter duration. In addition, hamsters receiving both macrophages not exposed to Formalin-inactivated B. burgdorferi (Mphi-NFBb) and enriched populations of either immune or naive T lymphocytes failed to develop severe swelling after infection with B. burgdorferi. No swelling was also observed in hamsters infused with both Mphi-FBb and enriched populations of immune T lymphocytes and then inoculated with spirochetal growth medium. We further showed that macrophages and enriched populations of T lymphocytes did not interact synergistically for controlling B. burgdorferi infection, as spirochetes were readily recovered from the tissues of all cell transfer recipients infected with B. burgdorferi. These findings demonstrate that hamsters infused with both Mphi-FBb and enriched populations of either immune or naive T lymphocytes develop a more fulminate arthritis after infection with B. burgdorferi than recipients infused with either cell type alone. These findings suggest that macrophages and T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis.

Full Text

The Full Text of this article is available as a PDF (369.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck G., Benach J. L., Habicht G. S. Isolation of interleukin 1 from joint fluids of patients with Lyme disease. J Rheumatol. 1989 Jun;16(6):800–806. [PubMed] [Google Scholar]
  2. Benach J. L., Fleit H. B., Habicht G. S., Coleman J. L., Bosler E. M., Lane B. P. Interactions of phagocytes with the Lyme disease spirochete: role of the Fc receptor. J Infect Dis. 1984 Oct;150(4):497–507. doi: 10.1093/infdis/150.4.497. [DOI] [PubMed] [Google Scholar]
  3. Benach J. L., Habicht G. S., Gocinski B. L., Coleman J. L. Phagocytic cell responses to in vivo and in vitro exposure to the Lyme disease spirochete. Yale J Biol Med. 1984 Jul-Aug;57(4):599–605. [PMC free article] [PubMed] [Google Scholar]
  4. Bertolini D. R., Nedwin G. E., Bringman T. S., Smith D. D., Mundy G. R. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature. 1986 Feb 6;319(6053):516–518. doi: 10.1038/319516a0. [DOI] [PubMed] [Google Scholar]
  5. Callister S. M., Case K. L., Agger W. A., Schell R. F., Johnson R. C., Ellingson J. L. Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi. J Clin Microbiol. 1990 Feb;28(2):363–365. doi: 10.1128/jcm.28.2.363-365.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Callister S. M., Schell R. F., Case K. L., Lovrich S. D., Day S. P. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J Infect Dis. 1993 Jan;167(1):158–164. doi: 10.1093/infdis/167.1.158. [DOI] [PubMed] [Google Scholar]
  7. Chang K. P. Leishmania donovani: promastigote--macrophage surface interactions in vitro. Exp Parasitol. 1979 Oct;48(2):175–189. doi: 10.1016/0014-4894(79)90097-3. [DOI] [PubMed] [Google Scholar]
  8. Defosse D. L., Johnson R. C. In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect Immun. 1992 Mar;60(3):1109–1113. doi: 10.1128/iai.60.3.1109-1113.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Du Chateau B. K., England D. M., Callister S. M., Lim L. C., Lovrich S. D., Schell R. F. Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters. Infect Immun. 1996 Jul;64(7):2540–2547. doi: 10.1128/iai.64.7.2540-2547.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fikrig E., Barthold S. W., Chen M., Grewal I. S., Craft J., Flavell R. A. Protective antibodies in murine Lyme disease arise independently of CD40 ligand. J Immunol. 1996 Jul 1;157(1):1–3. [PubMed] [Google Scholar]
  11. Filgueira L., Nestlé F. O., Rittig M., Joller H. I., Groscurth P. Human dendritic cells phagocytose and process Borrelia burgdorferi. J Immunol. 1996 Oct 1;157(7):2998–3005. [PubMed] [Google Scholar]
  12. Georgilis K., Steere A. C., Klempner M. S. Infectivity of Borrelia burgdorferi correlates with resistance to elimination by phagocytic cells. J Infect Dis. 1991 Jan;163(1):150–155. doi: 10.1093/infdis/163.1.150. [DOI] [PubMed] [Google Scholar]
  13. Keane-Myers A., Nickell S. P. Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J Immunol. 1995 Aug 15;155(4):2020–2028. [PubMed] [Google Scholar]
  14. Krause A., Brade V., Schoerner C., Solbach W., Kalden J. R., Burmester G. R. T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation. Arthritis Rheum. 1991 Apr;34(4):393–402. doi: 10.1002/art.1780340404. [DOI] [PubMed] [Google Scholar]
  15. Krause A., Burmester G. R., Rensing A., Schoerner C., Schaible U. E., Simon M. M., Herzer P., Kramer M. D., Wallich R. Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses. J Clin Invest. 1992 Sep;90(3):1077–1084. doi: 10.1172/JCI115923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lengl-Janssen B., Strauss A. F., Steere A. C., Kamradt T. The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J Exp Med. 1994 Dec 1;180(6):2069–2078. doi: 10.1084/jem.180.6.2069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lim L. C., England D. M., DuChateau B. K., Glowacki N. J., Creson J. R., Lovrich S. D., Callister S. M., Jobe D. A., Schell R. F. Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi. Infect Immun. 1994 Jul;62(7):2825–2833. doi: 10.1128/iai.62.7.2825-2833.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lim L. C., England D. M., DuChateau B. K., Glowacki N. J., Schell R. F. Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis. Infect Immun. 1995 Apr;63(4):1400–1408. doi: 10.1128/iai.63.4.1400-1408.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Liu H., Alder J. D., Steiner B. M., Stein-Streilein J., Lim L., Schell R. F. Role of L3T4+ and 38+ T-cell subsets in resistance against infection with Treponema pallidum subsp. pertenue in hamsters. Infect Immun. 1991 Feb;59(2):529–536. doi: 10.1128/iai.59.2.529-536.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Liu H., Steiner B. M., Alder J. D., Baertschy D. K., Schell R. F. Immune T cells sorted by flow cytometry confer protection against infection with Treponema pallidum subsp. pertenue in hamsters. Infect Immun. 1990 Jun;58(6):1685–1690. doi: 10.1128/iai.58.6.1685-1690.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lovrich S. D., Callister S. M., Schmitz J. L., Alder J. D., Schell R. F. Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete. Infect Immun. 1991 Aug;59(8):2522–2528. doi: 10.1128/iai.59.8.2522-2528.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ma Y., Seiler K. P., Tai K. F., Yang L., Woods M., Weis J. J. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect Immun. 1994 Sep;62(9):3663–3671. doi: 10.1128/iai.62.9.3663-3671.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Matyniak J. E., Reiner S. L. T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med. 1995 Mar 1;181(3):1251–1254. doi: 10.1084/jem.181.3.1251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. McAlister H. F., Klementowicz P. T., Andrews C., Fisher J. D., Feld M., Furman S. Lyme carditis: an important cause of reversible heart block. Ann Intern Med. 1989 Mar 1;110(5):339–345. doi: 10.7326/0003-4819-110-5-339. [DOI] [PubMed] [Google Scholar]
  25. McCartney-Francis N., Allen J. B., Mizel D. E., Albina J. E., Xie Q. W., Nathan C. F., Wahl S. M. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med. 1993 Aug 1;178(2):749–754. doi: 10.1084/jem.178.2.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Miller L. C., Lynch E. A., Isa S., Logan J. W., Dinarello C. A., Steere A. C. Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet. 1993 Jan 16;341(8838):146–148. doi: 10.1016/0140-6736(93)90006-3. [DOI] [PubMed] [Google Scholar]
  27. Neumann A., Schlesier M., Schneider H., Vogt A., Peter H. H. Frequencies of Borrelia burgdorferi-reactive T lymphocytes in Lyme arthritis. Rheumatol Int. 1989;9(3-5):237–241. doi: 10.1007/BF00271888. [DOI] [PubMed] [Google Scholar]
  28. Pachner A. R., Steere A. C. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology. 1985 Jan;35(1):47–53. doi: 10.1212/wnl.35.1.47. [DOI] [PubMed] [Google Scholar]
  29. Peterson P. K., Clawson C. C., Lee D. A., Garlich D. J., Quie P. G., Johnson R. C. Human phagocyte interactions with the Lyme disease spirochete. Infect Immun. 1984 Nov;46(2):608–611. doi: 10.1128/iai.46.2.608-611.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Preac-Mursic V., Weber K., Pfister H. W., Wilske B., Gross B., Baumann A., Prokop J. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection. 1989 Nov-Dec;17(6):355–359. doi: 10.1007/BF01645543. [DOI] [PubMed] [Google Scholar]
  31. Rao T. D., Frey A. B. Protective resistance to experimental Borrelia burgdorferi infection of mice by adoptive transfer of a CD4+ T cell clone. Cell Immunol. 1995 May;162(2):225–234. doi: 10.1006/cimm.1995.1073. [DOI] [PubMed] [Google Scholar]
  32. Rittig M. G., Häupl T., Burmester G. R. Coiling phagocytosis: a way for MHC class I presentation of bacterial antigens? Int Arch Allergy Immunol. 1994;103(1):4–10. doi: 10.1159/000236598. [DOI] [PubMed] [Google Scholar]
  33. Rittig M. G., Häupl T., Krause A., Kressel M., Groscurth P., Burmester G. R. Borrelia burgdorferi-induced ultrastructural alterations in human phagocytes: a clue to pathogenicity? J Pathol. 1994 Jul;173(3):269–282. doi: 10.1002/path.1711730311. [DOI] [PubMed] [Google Scholar]
  34. Rittig M. G., Krause A., Häupl T., Schaible U. E., Modolell M., Kramer M. D., Lütjen-Drecoll E., Simon M. M., Burmester G. R. Coiling phagocytosis is the preferential phagocytic mechanism for Borrelia burgdorferi. Infect Immun. 1992 Oct;60(10):4205–4212. doi: 10.1128/iai.60.10.4205-4212.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Roessner K., Fikrig E., Russell J. Q., Cooper S. M., Flavell R. A., Budd R. C. Prominent T lymphocyte response to Borrelia burgdorferi from peripheral blood of unexposed donors. Eur J Immunol. 1994 Feb;24(2):320–324. doi: 10.1002/eji.1830240207. [DOI] [PubMed] [Google Scholar]
  36. Schaible U. E., Wallich R., Kramer M. D., Nerz G., Stehle T., Museteanu C., Simon M. M. Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone. Int Immunol. 1994 May;6(5):671–681. doi: 10.1093/intimm/6.5.671. [DOI] [PubMed] [Google Scholar]
  37. Schmitz J. L., Schell R. F., Hejka A. G., England D. M. Passive immunization prevents induction of Lyme arthritis in LSH hamsters. Infect Immun. 1990 Jan;58(1):144–148. doi: 10.1128/iai.58.1.144-148.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Steere A. C., Bartenhagen N. H., Craft J. E., Hutchinson G. J., Newman J. H., Rahn D. W., Sigal L. H., Spieler P. N., Stenn K. S., Malawista S. E. The early clinical manifestations of Lyme disease. Ann Intern Med. 1983 Jul;99(1):76–82. doi: 10.7326/0003-4819-99-1-76. [DOI] [PubMed] [Google Scholar]
  39. Steere A. C., Brinckerhoff C. E., Miller D. J., Drinker H., Harris E. D., Jr, Malawista S. E. Elevated levels of collagenase and prostaglandin E2 from synovium associated with erosion of cartilage and bone in a patient with chronic Lyme arthritis. Arthritis Rheum. 1980 May;23(5):591–599. doi: 10.1002/art.1780230511. [DOI] [PubMed] [Google Scholar]
  40. Steere A. C., Gibofsky A., Patarroyo M. E., Winchester R. J., Hardin J. A., Malawista S. E. Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis. Ann Intern Med. 1979 Jun;90(6):896–901. doi: 10.7326/0003-4819-90-6-896. [DOI] [PubMed] [Google Scholar]
  41. Steere A. C. Lyme disease. N Engl J Med. 1989 Aug 31;321(9):586–596. doi: 10.1056/NEJM198908313210906. [DOI] [PubMed] [Google Scholar]
  42. Steere A. C., Schoen R. T., Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med. 1987 Nov;107(5):725–731. doi: 10.7326/0003-4819-107-5-725. [DOI] [PubMed] [Google Scholar]
  43. Stevens D. R., Moulton J. E. Ultrastructural and immunological aspects of the phagocytosis of Trypanosoma brucei by mouse peritoneal macrophages. Infect Immun. 1978 Mar;19(3):972–982. doi: 10.1128/iai.19.3.972-982.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wallach F. R., Murray H. W. Lymphocyte proliferation assay in Lyme disease. J Infect Dis. 1992 Oct;166(4):938–939. doi: 10.1093/infdis/166.4.938-a. [DOI] [PubMed] [Google Scholar]
  45. Weinberg J. B., Granger D. L., Pisetsky D. S., Seldin M. F., Misukonis M. A., Mason S. N., Pippen A. M., Ruiz P., Wood E. R., Gilkeson G. S. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med. 1994 Feb 1;179(2):651–660. doi: 10.1084/jem.179.2.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Witte P. L., Stein-Streilein J., Streilein J. W. Description of phenotypically distinct T-lymphocyte subsets which mediate helper/DTH and cytotoxic functions in the Syrian hamster. J Immunol. 1985 May;134(5):2908–2915. [PubMed] [Google Scholar]
  47. Witte P. L., Streilein J. W. Monoclonal antibodies to hamster class II MHC molecules distinguish T and B cells. J Immunol. 1983 May;130(5):2282–2286. [PubMed] [Google Scholar]
  48. Yoshinari N. H., Reinhardt B. N., Steere A. C. T cell responses to polypeptide fractions of Borrelia burgdorferi in patients with Lyme arthritis. Arthritis Rheum. 1991 Jun;34(6):707–713. doi: 10.1002/art.1780340611. [DOI] [PubMed] [Google Scholar]
  49. Yssel H., Nakamoto T., Schneider P., Freitas V., Collins C., Webb D., Mensi N., Soderberg C., Peltz G. Analysis of T lymphocytes cloned from the synovial fluid and blood of a patient with Lyme arthritis. Int Immunol. 1990;2(11):1081–1089. doi: 10.1093/intimm/2.11.1081. [DOI] [PubMed] [Google Scholar]
  50. Yssel H., Shanafelt M. C., Soderberg C., Schneider P. V., Anzola J., Peltz G. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med. 1991 Sep 1;174(3):593–601. doi: 10.1084/jem.174.3.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Zoschke D. C., Skemp A. A., Defosse D. L. Lymphoproliferative responses to Borrelia burgdorferi in Lyme disease. Ann Intern Med. 1991 Feb 15;114(4):285–289. doi: 10.7326/0003-4819-114-4-285. [DOI] [PubMed] [Google Scholar]
  52. di Tommaso A., de Magistris M. T., Bugnoli M., Marsili I., Rappuoli R., Abrignani S. Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing. Infect Immun. 1994 May;62(5):1830–1834. doi: 10.1128/iai.62.5.1830-1834.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES